Search

Memorial Sloan Kettering Cancer Center (MSK) announces the November 2022 awards and appointments.

… Thursday, December 1, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Tania Bubb Tania Bubb Elected President of The Association for Professionals in Infection Control and Epidemiology Tania Bubb, PhD, RN, Senior Director of Infection Control, has been

New findings on several important lung cancer clinical trials were presented at the 2025 Annual Meeting of the American Society of Clinical Oncology.

… Monday, June 2, 2025 Researchers from Memorial Sloan Kettering Cancer Center (MSK) reported important advances in the treatment of lung cancer  at the annual meeting of the American Society of Clinical Oncology (ASCO), held May 30 to June 3 in Chicago. Scientists presented promising results on three

Dr. Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at MSK studying the genetics of blood cancers.

… Monday, June 8, 2020 Summary Linde Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering. She is a 2020 winner of a Kravis Women in Science Endeavor (WiSE) Postdoctoral Fellowship . Dr. Miles will be presenting her research at the inaugural Kravis WISE

Metastasis — the spreading of cancer from its original location to a new location — can be broken down into three main stages: dissemination, dormancy, and outbreak.

… Thursday, July 1, 2021 Illustration explaining the stages of cancer metastasis Click to enlarge » Metastasis — the spreading of cancer from its original location to a new location — can be broken down into three main stages: dissemination, dormancy, and outbreak. Memorial Sloan Kettering researchers

Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions.

… Friday, March 22, 2019 Summary Researchers have long pondered a possible link between drinking coffee and cancer risk. The evidence has been confusing and largely inconclusive. In recent years, intriguing research has suggested that drinking coffee might protect against colorectal cancer. A study published

Integrative medicine specialists determine which complementary therapies appear to be most effective.

… Thursday, May 18, 2017 Summary Though many people with cancer use complementary therapies, there is still some debate about which practices are truly effective. A new study suggests that mind-body therapies, such as meditation and yoga, have the best track record. Studies indicate that many people with

In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.

… Monday, February 1, 2010 Summary In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States. People don’t usually think of math when

Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents.

… Thursday, November 8, 2018 Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents, according to data we presented at the American Society of Clinical Oncology’s annual meeting

In this Q&A we discuss MSK’s pioneering work in rectal MRI, how it differs from endorectal ultrasound (ERUS), its role in groundbreaking clinical trials for patients with rectal cancer, why expertise matters, and new frontiers for future improvements to rectal MRI.

… Thursday, June 26, 2025 A Q&A with Dr. Marc J. Gollub, MSK’s Director of Gastrointestinal Radiology Memorial Sloan Kettering Cancer Center (MSK) has one of the busiest rectal cancer practices and likely performs the most rectal magnetic resonance imaging (MRI) exams in the United States. In this Q&A

A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.

… Thursday, April 3, 2008 A study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells. Metastasis is the cause of approximately 90 percent of all cancer-related deaths.